Name: J-COF DHC
- J-COF DHC j-cof dhc drug
- J-COF DHC drug
- J-COF DHC effects of
- J-COF DHC used to treat
- J-COF DHC dosage
- J-COF DHC usual dose
- J-COF DHC mg
J-Cof DHC Drug Class
J-Cof DHC is part of the drug classes:
Natural opium alkaloids
Antihistamines should not be used to treat or lower respiratory tract symptoms or be given to premature or newborn infants.
Sympathomemetic agents are contraindicated in patients with severe hypertension, severe coronary artery disease, patients with narrow angle glaucoma, bronchial asthma, urinary retention, peptic ulcer, and during an asthmatic attack. This product is contraindicated in women who are pregnant.
Usage in Ambulatory Patients: Dihydrocodeine may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery.
Respiratory Depression: Respiratory depression is the most dangerous acute reaction produced by opioid agonist preparations, although it is rarely severe with usual doses. Opioids decrease the respiratory tidal volume, minute ventilation, and sensitivity to carbon dioxide. Respiratory depression occurs most frequently in elderly or debilitated patients, usually after large initial doses in non-tolerant patients, or when opioids are given in conjunction with other agents that depress respiration. This combination product should be used with caution in patients with significant chronic obstructive pulmonary disease or cor pulmonale and in patients with a substantially decreased respiratory reserve, hypoxia, hypercapnia, or respiratory depression.
Hypertensive Effect: Dihydrocodeine, like all opioid analgesics, may cause hypotention in patients whose ability to maintain blood pressure has been compromised by depleted blood volume or who received concurrent therapy with drugs such as phenothiazine or other agents which compromise vasomotor tone. This product may produce orthostatic hypotension in ambulatory patients. This combination product should be administered with caution to patients with circulatory shock since vasodilation produced by the drug may further reduce cardiac output and blood pressure.
Dependence: Dihydrocodeine can produce drug dependence of the codeine type and has the potential of being abused. This product should be prescribed and administered with the appropriate degree of caution (See Drug Abuse and Dependence section).
Principal display panel and side panel for 473 mL label:
Each teaspoonful (5 mL) for oral
Dihydrocodeine Bitartrate...............................7.5 mg
(WARNING: May be habit forming)
Brompheniramine Maleate................................3 mg
Pseudoephedrine HCl.....................................15 mg
SUGAR FREE · ALCOHOL FREE
16 fl oz (473 mL)
USUAL DOSAGE: Adults and children over 12 years of age: 1 to 2 teaspoonfuls (5 mL to 10 mL),
every 4 to 6 hours as needed. Children 6 to 12 years of age: 1/2 to 1 teaspoonful (2.5 mL to 5 mL),
every 4 to 6 hours as needed.
For full prescribing information see attached insert.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
IN CASE OF ACCIDENTAL OVERDOSE, SEE PROFESSIONAL ASSISTANCE
OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.
Store at controlled room temperature, 15°-30°C (59°-86°F).
Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant
Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.
Mfg. by: Great Southern Laboratories, Houston, TX 77099
Mfg. for: JayMac Pharmaceuticals, Sunset, LA 70584
|J-COF DHC |
dihydrocodeine bitartrate, brompheniramine maleate, pseudoephedrine hydrochloride liquid
|Labeler - JayMac Pharmaceuticals (830767260)|
|Registrant - Great Southern Laboratories (056139553)|
|Great Southern Laboratories||056139553||manufacture|